Multimeric Biotherapeutics, Inc.
Powerful FortiVac vaccine platform technology for CD8+ T cells against cancer and viruses. Seeking to license the technology or find an investor to help move FortiVac into the clinic. The lead indication is human papillomavirus (HPV)-associated cancer esp. cervical cancer in the field of Women's health.
Our Company Presentation will be on Tuesday, February 11 at 9:45-9:58 AM in the Plymouth Room.
Address
La JollaCalifornia
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}